Cesar Arias
@SuperBugDoc
Followers
3K
Following
1K
Media
107
Statuses
1K
Fan of bugs, resistance genes and salsa dancing Editor in Chief, Antimicrobial Agents and Chemotherapy;
Houston, TX
Joined June 2019
An enriching experience to talk about AMR at the "Editors in Conversation" podcast in India with Prof. Anuradha Chowdhary (@UnivofDelhi) and hosted by Prof. Cesar A. Arias @SuperBugDoc Link: https://t.co/4WkiAMOgAf
@ASMicrobiology
1
2
16
Countdown to IMARI 2026, Pre-meeting workshop : Microbiomes as Reservoirs, Catalysts, and Solutions for AMR. Outstanding Speakers (Drs Derick Crook, Cesar De La Fuente, Ashley Earl, Mary Hayden and Michael Woodworth. @IDSAInfo @ASMicrobiology
https://t.co/sXlXw1gKky
imari.org
Visit the post for more.
0
4
9
The draft for the 2026 IDSA/ESCMID clinical practice guidelines on 𝘚. 𝘢𝘶𝘳𝘦𝘶𝘴 bacteraemia is now available for public consultation. Get your copy of the manuscript and submit your feedback before 15 December 2025. https://t.co/8yCFmFLqLW
2
21
62
Determining minimum inhibitory concentrations (MICs) is essential for evaluating antimicrobial efficacy. How to optimize the process? This #AACJournal study tests reducing broth microdilution assay volumes w/o compromising MIC accuracy. Get the results: https://t.co/hAYMi0vc3A
1
44
105
Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations | Antimicrobial Agents and Chemotherapy ( https://t.co/4V1yOAoDQh)
@SuperBugDoc @ASMicrobiology
0
57
135
IMARI 2026New Antimicrobial Agents Session featuring that are in or entering clinical development. Deadline: December 1, 2025, by 2:00 p.m. ET Notification: December 17, Eligibility Requirements at
imari.org
Visit the post for more.
0
2
4
High-risk clonal expansion of IMP-producing Enterobacter cloacae complex in regional Japanese healthcare settings | Antimicrobial Agents and Chemotherapy ( https://t.co/j8l5cUp2zN)
@SuperBugDoc @ASMicrobiology
2
18
32
New issue #AACJournal now out incluidng a minireview of Achromobacter infections, Targeting CARD9 with Small-Molecule Therapeutics, safety of omadacycline in patients with hepatic impairment and much more... @ASMicrobiology @ARLGnetwork
0
10
20
Deadline for abstract submission @ASMicrobiology @IDSAInfo #IMARI2026 is tomorrow October 1.. Amazing program already in place.. Two outstanding pre-meeting workshops on Pk/PD and Genomics/Microbiome and AMR
imari.org
Visit the post for more.
0
3
5
Abstract deadline for the @ASMicrobiology and @IDSAInfo IMARI 2026 (Interdisciplinary Meeting on Antimicrobial Resistance & Innovation) in Las Vegas, NV is October 1 Registration now OPEN!! @asm_tmc @ARLGnetwork
https://t.co/sXlXw1gcv0
imari.org
Visit the post for more.
0
6
7
How does Pseudomonas aeruginosa colistin resistance evolve in biofilms? Researchers shine a light on this question in #AACJournal, uncovering similarities and differences in the dynamics of colistin resistance under biofilm and planktonic growth. https://t.co/CiftPVXYJL
0
1
1
How does Pseudomonas aeruginosa colistin resistance evolve in biofilms? Researchers shine a light on this question in #AACJournal, uncovering similarities and differences in the dynamics of colistin resistance under biofilm and planktonic growth. https://t.co/CiftPVXYJL
2
15
50
@SuperBugDoc 🙌🏼
Multidrug-resistant enterococcal infections continue to be a major clinical challenge! 🆕💫Mini Review #AAC Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections #IDXposts
https://t.co/Q29V51nohY
0
6
14
In the latest episode of Editors in Conversation, we discuss the raise of measles, cliniucal manifestations and mitigation measure with truly outstanding experts in the field @ASMicrobiology @asm_tmc
asm.org
Measles as an important public health threat, the origin of the epidemic, accurate information on countermeasures and strategies to tackle this outbreak.
0
3
11
Journal reviewers are the core of our scientific mission. #AACJournal celebrates our top reviewers and would be eternally grateful for their contributions @ASMicrobiology
0
9
23
Two FDA-approved antifungal medications, oxiconazole and sertaconazole, restore antibiotic susceptibility in multidrug-resistant Staphylococcus aureus by inhibiting efflux pumps. Learn more about their potential as efflux pump inhibitors in #AACJournal: https://t.co/FOF2KmRunX
0
1
2
Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidence. https://t.co/r4naeWQLeQ
0
45
118
Recognizing Dr. Murray’s significant contributions to the field of #InfectiousDisease, the @ARLGnetwork renamed our Early Stage Investigator award in her honor. Dr. Murray's commitment to the field will live on through researchers receiving this award. @UTHealthHouston
0
1
9
Website of IMARI (Interdisciplinary Meeting on Antimicrobial Resistance and Innovation; January 28-30, 2026, Las Vegas!) https://t.co/sXlXw1gcv0
@ASM and @IDSAInfo. Abstract submission now OPEN Deadline: Wednesday, October 1, Dispositions: October 22 @ARLGnetwork
imari.org
Visit the post for more.
0
8
16
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS) ✅ Just Accepted ✍️ @SuperBugDoc @MethodistHosp 🔗 https://t.co/6tWkrdrD0H
1
1
3